After years of campaigning, PHARMAC agrees to fund 'wonder drug' to treat kids with cystic fibrosis

24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund the long-campaigned for drug Kalydeco ...

Read more →

FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

23 January 2020 - Today, the U.S. Food and Drug Administration granted accelerated approval to Tazverik (tazemetostat) for the treatment of ...

Read more →

PHARMAC seeking views on new cystic fibrosis medicine

24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...

Read more →

ICER releases draft evidence report on therapies for sickle cell disease

23 January 2020 - ICER’s ongoing assessment emphasises that policy makers will need to consider, in addition to traditional measures ...

Read more →

Ready for rescue – new nasally administered glucagon for severe hypoglycaemia available in Canada

23 January 2020 - Eli Lilly Canada introduces Baqsimi, another Canadian innovation to help manage diabetes complications. ...

Read more →

HLS Therapeutics files new drug submission for Perseris in Canada

23 January 2020 - If approved by Health Canada, Perseris would become the first once-monthly risperidone long-acting injectable used in the ...

Read more →

Health Canada approves Keytruda (pembrolizumab) as first-line treatment for patients with advanced renal cell carcinoma

23 January 2020 - Approval based on results of KEYNOTE-426, Where Keytruda in combination with axitinib reduced the risk of death ...

Read more →

Health Technology Assessment around the world: broadening the understanding of cross-country differences

22 January 2020 - Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, ...

Read more →

Woman denied cancer drug on NHS which could extend her life because of where she lives

22 January 2020 - Ann, 64, can't get the drug she needs to survive because it's not available on the NHS ...

Read more →

PHARMAC protest ride from Dunedin ends with conflict in Parliament

22 January 2020 - A couple’s tandem cycle ride from Dunedin to Wellington, to call for increased PHARMAC funding, has ...

Read more →

The intricacies of rising drug prices in the US

23 January 2020 - Following 250 US drug price increases in 2020 already, this article explores why costs are rising, what ...

Read more →

Want to know how contentious drug pricing is in Washington? Check the receipts.

23 January 2020 - Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that belong to the ...

Read more →

Baudax Bio announces PDUFA date for intravenous meloxicam

22 January 2020 - Baudax Bio today announced that the U.S. FDA has set a PDUFA goal date of 20 ...

Read more →

Sick of high drug prices, insurers join hospitals to make their own generic medications

23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...

Read more →

Update of the frequently asked questions for the PBS Botulinum Toxin Program

23 January 2020 - A revised version of the frequently asked questions for the PBS Botulinum Toxin Program is now available. ...

Read more →